Trader play it safe ahead of Fed meeting

Tonight's minutes will give us an insight into why the US central bank decided to trim its bond-buying scheme, and we are likely to see low volumes and volatility until then. 

In mid-morning trading the FTSE 100 is down 20 points due to cautious traders ahead of the Federal Reserve minutes tonight. In London the focus is instead on corporate updates as we enter reporting season. 

Persimmon is pushing ahead, revealing a 21% jump in full-year revenues, no doubt assisted by the Help to Buy scheme. 

Mothercare is off 31% after the company issued yet another profit warning. 

Lloyds has gained 1% after a report suggesting that the government is looking to unwind its shareholding in the troubled lender. Given the success of the Royal Mail flotation, the disposal might come in the form of a general sale to the public. 

Sainsbury's announced a slight increase in like-for-like sales in the 14 weeks before January, while Lidl and Aldi are eating into their profits. 

In the US we are expecting the Dow Jones to open 20 points lower at 16,510. 

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.